The Chemours Company (NYSE:CC) Q4 2025 Earnings Call Transcript
The Chemours Company (NYSE:CC) held its Q4 2025 earnings call, discussing recent developments, financial performance, and the 2026 outlook. Key highlights include the sale of the Kuan Yin site for an estimated $300 million to reduce debt, strong performance in its TSS business driven by Opteon adoption, and strategic adjustments in the TT and APM segments to promote cash flow despite market headwinds and operational disruptions. The company remains committed to its Pathway to Thrive strategy, focusing on operational excellence, enabling growth, portfolio management, and strengthening long-term financial stability.
These Stocks Are Today’s Movers: Grail, Corning, Opendoor, Akamai, AppLovin, Chemours, and More
The article highlights several market-moving stocks including Grail, Corning, Comfort Systems USA, Opendoor, Akamai, and Chemours. These stocks traded higher on Friday following a Supreme Court ruling against tariffs previously imposed by President Donald Trump under the International Emergency Economic Powers Act.
Appeals Court will not review Cumberland suit against DuPont, Chemours
The North Carolina Court of Appeals has denied DuPont and Chemours’ request to review a public nuisance lawsuit filed against them by Cumberland County. This lawsuit is distinct from actions taken by the state government against Chemours and concerns PFAS contamination from the Fayetteville Works plant. The county argues that the companies used the area as a dumping ground and is seeking remedies for the alleged public health nuisance.
Chemours (CC) Reports Q4 Earnings Miss Amid APM Segment Challenges
Chemours (CC) reported a significant Q4 earnings miss, with an 11.3% drop in pre-market trading, primarily due to declining sales and profitability in its Advanced Performance Materials (APM) segment. The company recorded a net loss of $47 million and a substantial decrease in adjusted EBITDA for both the APM and Titanium Technologies segments. Financial health indicators, including a high debt-to-equity ratio and a low Altman Z-Score, suggest potential distress and pose risks for investors.
Chemours Stock Tumbles After Earnings. Data-Center Cooling Couldn’t Save the Quarter.
Chemours stock experienced a sharp decline following a weaker-than-expected earnings report, despite the growth in data-center cooling markets. Prior to this drop, the company's stock had seen significant gains, rising 73% year-to-date and 16% over the past year. However, these positive trends were not enough to offset the disappointing quarterly performance.
Chemours (CC) Q4 2025 Earnings Call Transcript
Chemours (CC) reported its Q4 2025 earnings, highlighting $300 million in net proceeds from the Kuan Yin site sale for debt reduction and strong free cash flow generation of $92 million. The company projects 3-5% net sales growth and $800-900 million in adjusted EBITDA for the full year 2026, driven by growth in Thermal & Specialized Solutions (TSS) and Advanced Performance Materials (APM), pricing strength in Titanium Technologies (TT), and cost-saving initiatives. Management also discussed strategic actions including TT mining restructuring, capacity expansion at Corpus Christi, and progress in addressing legacy liabilities.
Chemours slides 11% on Q4 weakness in advanced performance materials (CC:NYSE)
Chemours (CC) shares fell 11% in pre-market trading after reporting weaker-than-expected Q4 adjusted earnings, primarily due to declining sales in its advanced performance materials segment. The company's Q4 net loss increased, and adjusted EBITDA fell significantly year-over-year. Despite the poor Q4 performance, Chemours provided a full-year revenue growth forecast of 3%-5% and adjusted EBITDA of $800M-$900M, which aligns with analyst expectations.
Chemours: Fourth Quarter Earnings Overview
Chemours Co. reported a net loss of $47 million for the fourth quarter, or 31 cents per share. However, adjusted earnings, excluding one-time expenses, reached 5 cents per share, surpassing Wall Street expectations. The company also generated $1.33 billion in revenue, which met analysts' forecasts.
Earnings Flash (CC) Chemours Posts Q4 Adjusted EPS $0.05, vs. FactSet Est of $0.07
The Chemours Company reported Q4 adjusted earnings per share of $0.05, falling short of FactSet's estimate of $0.07. Revenue for the quarter was $1.33 billion, matching FactSet's estimate. The company's shares declined after hours following the announcement of decreased Q4 adjusted earnings and sales.
The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
The Chemours Company announced its financial results for the fourth quarter and full year 2025, with net sales of $1.3 billion and $5.8 billion, respectively. The company reported a net loss attributable to Chemours of $47 million in Q4 and $386 million for the full year, primarily driven by lower cost absorption, non-cash inventory charges, and litigation-related expenses. Despite macroeconomic headwinds, Chemours anticipates 2026 net sales growth of 3-5% and adjusted EBITDA between $800 million and $900 million, supported by Opteon™ Refrigerants demand and strategic cost reductions.
Chemours Co earnings missed by $0.02, revenue fell short of estimates
Chemours Co (NYSE: CC) reported fourth-quarter earnings per share of $0.05, missing the analyst estimate of $0.07 by $0.02. Revenue for the quarter also fell short, coming in at $1.3B against an estimated $1.33B. Despite the miss, Chemours Co's stock has seen significant gains, up 84.71% in the last three months and 16.76% in the last 12 months.
Chemours Co earnings missed by $0.02, revenue fell short of estimates
Chemours Co (NYSE: CC) reported fourth-quarter EPS of $0.05, missing analyst estimates by $0.02, and revenue of $1.3B, which fell short of the consensus estimate of $1.33B. Despite the miss, the company's stock price has shown significant growth, up 84.71% in the last three months and 16.76% in the last twelve months. The article also notes a higher number of negative EPS revisions compared to positive ones for Chemours Co recently.
Chemours: Q4 Earnings Snapshot
Chemours Co. reported a Q4 loss of $47 million, or 31 cents per share, though adjusted earnings of 5 cents per share surpassed analyst expectations. The company achieved revenue of $1.33 billion in the quarter, matching Street forecasts. For the full year, Chemours posted a loss of $386 million on revenue of $5.81 billion.
Titanium Dioxide Market to grow at 5.9% CAGR | Asia Pacific leads
The Titanium Dioxide Market is projected to grow at a CAGR of 5.9% from 2023 to 2030, driven by strong demand from industries like paints, coatings, plastics, and cosmetics. Asia Pacific is expected to lead the market with a 40% share due to its strong manufacturing base. Major companies such as The Chemours Company, Lomon Billions Group, and Tronox Holding PLC are strengthening the market through technological advancements, product innovations, and strategic expansions.
Pender Co. commissioners unanimously opposed Chemours’ Fayetteville expansion
The Pender County Board of Commissioners unanimously passed a resolution opposing the expansion of the Chemours Fayetteville Works Facility due to concerns about repeated underreporting of PFAS emissions and contamination of over 11,000 drinking water wells. The resolution calls for regulatory agencies to deny the expansion until sufficient remediation is completed and prioritizes the protection of North Carolina residents and natural resources. Pender County joins other local entities like New Hanover County and the Wilmington City Council in opposing the expansion.
Chemours announces quarterly dividend of $0.0875 per share
The Chemours Company (NYSE: CC) announced a quarterly cash dividend of $0.0875 per share for the first quarter of 2026, payable on March 13, 2026, to stockholders of record as of February 27, 2026. The company, a global provider of industrial and specialty chemicals, recently made strategic moves including selling a titanium dioxide manufacturing site for $360 million and appointing a new President for its Titanium Technologies business. BMO Capital also raised its price target for Chemours, maintaining an Outperform rating.
Pender Co. commissioners unanimously opposed Chemours’ Fayetteville expansion
The Pender County Board of Commissioners unanimously opposed Chemours' Fayetteville expansion during their regular meeting on February 17, 2026. The article provides only this detail about the opposition and is mainly filled with navigation links and suggestions for other local news stories.
Chemours declares quarterly cash dividend of $0.0875 per share on common stock for Q1 2026
The Chemours Company has announced a quarterly cash dividend of $0.0875 per share on its common stock for the first quarter of 2026. This announcement comes amidst recent analyst rating adjustments and news of the company's sale of a former titanium dioxide site in Taiwan. Chemours is a provider of performance chemicals with segments in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials.
Chemours Announces First Quarter Dividend
The Chemours Company (NYSE: CC) has announced that its Board of Directors has declared a quarterly cash dividend of $0.0875 per share for the first quarter of 2026. This dividend will be distributed on March 13, 2026, to stockholders on record as of February 27, 2026. Chemours is a global leader in industrial and specialty chemicals, serving various markets with products under brands like Opteon™, Freon™, and Teflon™.
Chemours Reaches Important Milestone in Its Sustainability Journey; Receives Approval of Science-Based Emissions Reduction Targets
The Chemours Company announced that the Science Based Target initiative (SBTi) has approved its near-term greenhouse gas emissions reduction targets. These targets include an absolute 60% reduction in Scope 1 and 2 GHG emissions by 2030 and a new Scope 3 target to reduce emissions by 25% per ton of production by 2030. This approval marks a critical milestone in Chemours' sustainability journey and underscores its commitment to addressing climate change through responsible manufacturing and sustainable offerings.
A crisis emerges across the US as 'forever chemicals' quietly contaminate drinking water wells
A widespread crisis is unfolding across the US as "forever chemicals" (PFAS) contaminate drinking water, particularly affecting the 40 million Americans relying on private wells. These chemicals, linked to serious health issues, are difficult to remove and often remain undetected in private water sources due to a lack of testing mandates and resources compared to municipal water systems. Communities like Stella, Wisconsin, and Peshtigo, Wisconsin, exemplify the devastating impact, with residents struggling with contaminated wells, decreased property values, and slow, inconsistent cleanup efforts by companies and states.
Chemours Recognized for Sustainability Achievements at the U.S. Department of Energy Better Buildings, Better Plants Summit
Chemours received two Better Plants Awards at the U.S. Department of Energy's annual summit for its sustainable manufacturing advancements. The awards recognized Chemours for implementing an internal bonus metric that reduced energy intensity by 3.5% across 14 sites and for achieving over $1 million in annual savings on waste disposal at its Corpus Christi, Texas facility. These accolades highlight the company's commitment to energy efficiency, waste reduction, and decarbonization strategies.
Sustainability at Chemours
Chemours is committed to responsible chemistry, reflected in its 2030 Corporate Responsibility Commitment (CRC) goals. The company recently completed its first Double Materiality Assessment (DMA) to refresh these goals, focusing on risks, impacts, and opportunities identified by stakeholders. This assessment helps Chemours address evolving sustainability challenges, comply with new regulations, and drive continuous improvement in areas like resource use, circularity, and creating an inclusive work environment.
How Chemours’ Chemistries Are Helping To Sustainably Scale the Hydrogen Economy
The article highlights how The Chemours Company's Nafion™ ion exchange materials are crucial for scaling the hydrogen economy, particularly in water electrolysis for producing renewable hydrogen. Chemours is investing significantly in increasing its production capacity for these materials globally, emphasizing the need for regulatory certainty and collaboration across sectors to accelerate the transition to a sustainable hydrogen future. The company believes that its advanced chemistries, combined with supportive policy frameworks and investments, are essential for meeting ambitious climate goals.
Precision Trading with Chemours Company (the) (CC) Risk Zones
This article provides a detailed analysis of Chemours Company (CC) with an emphasis on precision trading using AI-generated risk zones and strategies. It outlines different trading approaches—Position, Momentum Breakout, and Risk Hedging—along with their respective entry zones, targets, and stop losses. The analysis also highlights the stock's sentiment, resistance levels, and an exceptional risk-reward short setup, making it suitable for traders seeking actionable insights and risk management parameters.
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
Chemours (CC) is projected to report a year-over-year decline in earnings and lower revenues for the quarter ended December 2025. The company's Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in a negative Earnings ESP of -1,100.00% and a Zacks Rank of #4, suggesting it is difficult to conclusively predict an earnings beat. Investors are advised to consider other factors beyond just the earnings report when making investment decisions.
Chemours Co stock hits 52-week high at 18.47 USD
Chemours Co stock reached a 52-week high of $18.47, reflecting strong investor confidence and significant gains over the past six months despite the company operating with substantial debt. Analysts predict profitability this year, with an EPS of $0.91. Recent corporate actions include selling a former manufacturing site for $360 million and executive appointments, alongside varied price targets from BMO Capital and Truist Securities.
Chemours Co stock hits 52-week high at 18.47 USD By Investing.com
Chemours Co (CC) stock recently hit a 52-week high of $18.47, reflecting significant investor confidence and market performance with a 17.59% gain in the last week and a 52.25% surge over six months, despite the company operating with significant debt. Analysts forecast profitability for the current year, and the company has strategic moves underway, including a land sale and executive appointment. BMO Capital raised its price target to $20 with an Outperform rating, while Truist Securities lowered its target to $18 due to demand challenges.
Chemours Co stock hits 52-week high at 18.47 USD
Chemours Co (CC) stock recently hit a 52-week high of $18.47 USD, showing significant investor confidence despite the company operating with significant debt and not being profitable in the last year. Analysts are optimistic about future profitability, forecasting an EPS of $0.91 for the current year. The company is actively making strategic moves, including the sale of a manufacturing site for approximately $360 million and key leadership appointments, while analysts offer varied price targets reflecting market dynamics.
Assessing Chemours (CC) Valuation After A Sharp Share Price Rebound
Chemours (CC) has seen a significant share price rebound recently, though it trades above analyst targets but with a high estimated intrinsic discount. While a cash flow-based valuation suggests it's overvalued at $18.32 compared to a fair value of $16.33, its low P/S ratio compared to the industry indicates a potential valuation mismatch that could either be a margin of safety or a sign of future challenges. Investors are encouraged to consider the full narrative, potential risks like PFAS litigation, and other valuation metrics to form their own conclusions.
New York State Common Retirement Fund Buys 425,642 Shares of The Chemours Company $CC
The New York State Common Retirement Fund significantly increased its stake in The Chemours Company (NYSE:CC) by 1,085.8% in Q3, acquiring 425,642 additional shares to reach a total of 464,842 shares valued at approximately $7.36 million. Despite this increased institutional interest, analysts maintain a "Hold" consensus rating with an average price target of $16.67. Chemours recently reported mixed financial results, with revenue aligning with expectations but EPS missing forecasts, and the stock is currently trading near its 12-month high.
Chemours (CC) Passes Through 2% Yield Mark
Chemours Co (CC) shares recorded a yield above the 2% mark, based on its quarterly dividend. The article highlights the importance of dividends for total stock market returns, using an example of the iShares Russell 3000 ETF, and suggests that a sustainable 2% yield for Chemours would be attractive. The article also mentions Chemours Co's status as a Russell 3000 member.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) announced its plans to issue fourth quarter 2025 financial results after market on Thursday, February 19, 2026. A conference call to discuss these results will be held at 8:00 a.m. Eastern Time on Friday, February 20, 2026. The webcast and accompanying materials will be accessible through the "Events and Presentations" section of Chemours' investor relations website.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) announced it will release its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. A conference call to discuss these results will be held on Friday, February 20, 2026, at 8:00 a.m. Eastern Time. The call will be accessible to the public via webcast on the company's investor relations website.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) announced its plans to release its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. The company will host a conference call and webcast to discuss these results at 8:00 a.m. Eastern Time on Friday, February 20, 2026, which will be accessible via its investor relations website.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) announced it will release its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. A conference call to discuss these results will be held at 8:00 a.m. Eastern Time on Friday, February 20, 2026, which will be accessible via webcast on the company's investor relations website.
Chemours earnings up next as TiO2 recovery hopes meet weak quarter
Chemours (CC) is set to report its fourth-quarter earnings, with analysts expecting a significant decline in EPS and revenue. Investors will be keenly watching for signs of recovery in the company's titanium dioxide (TiO2) business, progress in its data center cooling platform, and updates on debt reduction plans. Despite near-term challenges, there's growing optimism for long-term prospects, particularly for TiO2 recovery in 2026/27.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) announced it will release its fourth quarter 2025 financial results after market on Thursday, February 19, 2026. A conference call to discuss these results will be held at 8:00 a.m. Eastern Time on Friday, February 20, 2026, accessible to the public via webcast on the company's investor relations website.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) announced it will release its fourth-quarter 2025 financial results after market on Thursday, February 19, 2026. A conference call to discuss these results will be held on Friday, February 20, 2026, at 8:00 a.m. Eastern Time, accessible via webcast on the company's investor relations website. Chemours is a global leader in industrial and specialty chemical products, operating in diverse markets with flagship brands like Opteon™, Freon™, and Teflon™.
Chemours Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
The Chemours Company (NYSE: CC) has announced that it will release its fourth-quarter 2025 financial results after market on Thursday, February 19, 2026. The company will also hold a conference call to discuss these results on Friday, February 20, 2026, at 8:00 a.m. Eastern Time. The webcast and accompanying materials will be accessible through the investor relations section of Chemours' website.
Chemours earnings up next as TiO2 recovery hopes meet weak quarter
Chemours Co. (NYSE: CC) is set to release its fourth-quarter results, with analysts expecting earnings of 7 cents per share on revenue of $1.33 billion, a significant decline from the previous quarter. Investors will be closely watching for recovery signs in its titanium dioxide business and progress in its data center cooling platform. Despite a challenging quarter and reduced EPS estimates, long-term optimism is growing, with potential for a TiO2 market turnaround in 2026/27.
Chemours Strengthens Balance Sheet Amid Operational and Environmental Scrutiny
Chemours is taking steps to improve its financial health by divesting a former manufacturing site in Taiwan for $360 million, with proceeds aimed at debt reduction. Concurrently, the company has appointed Michael Foley to lead its struggling Titanium Technologies segment, aiming for a turnaround. These strategic moves come as Chemours navigates ongoing operational challenges, anticipation of Q4 2025 results, and persistent environmental liabilities related to PFAS.
Chemours Scores Relative Strength Rating Upgrade; Hits Key Threshold
Chemours (CC) has received an upgrade to its Relative Strength (RS) Rating, reaching a new score of 83. This upgrade indicates improving technical performance, as the RS Rating identifies a stock's price performance from 1 (worst) to 99 (best). Investors often look for stocks with an RS Rating of 80 or higher for their watch lists, a criterion Chemours now meets.
A crisis emerges across the US as ‘forever chemicals’ quietly contaminate drinking water wells
The article details how "forever chemicals" (PFAS) are contaminating private drinking water wells across the U.S., posing health risks and creating significant challenges for affected communities. It highlights the struggles of residents in places like Stella, Wisconsin, and near the Cape Fear River in North Carolina, where contamination from industrial sources has gone largely unaddressed due to a lack of federal regulations for private wells and insufficient state funding. The piece emphasizes the financial burdens on well owners and the complexities of cleanup, with some communities facing long delays and partial solutions.
The Chemours Company (NYSE:CC) Shares Fly 27% But Investors Aren't Buying For Growth
The Chemours Company (NYSE:CC) saw its share price surge 27% in the last month, though it's still down 14% over the past year. Despite this recent jump, its Price-to-Sales (P/S) ratio of 0.4x remains low compared to the industry average, suggesting investors are not buying for growth. Analysts forecast lower revenue growth for Chemours (4.0% per year) than for the broader Chemicals industry (8.8% per year), contributing to its suppressed P/S ratio and indicating limited investor confidence in its future growth potential.
When forever chemicals contaminate drinking water, private well owners may be the last to know
Private well owners in the U.S. face a significant risk from PFAS contamination, often being the last to discover tainted water due to a lack of federal regulations and testing mandates that apply to public utilities. Communities like Stella, Wisconsin, and areas along North Carolina's Cape Fear River illustrate how these persistent chemicals, linked to serious health issues, seep into groundwater from industrial sources, leaving residents with costly and uncertain solutions. Many states struggle to fund remediation efforts, putting the burden disproportionately on individual well owners who relied on their water for years without knowing the dangers.
Chemical and materials giant cutting jobs at Georgia mining facilities
Chemours, a chemical and materials company, is laying off over a third of its Georgia workforce, affecting 54 of 142 employees at three mining facilities. These job cuts come as the company continues to face pressure regarding its mining plans near Georgia's Okefenokee Swamp, a contentious issue due to environmental concerns and the area's fragile hydrology. The company stated the layoffs are part of a shift in operations to focus on high-value minerals and improve efficiency.
Technical Reactions to CC Trends in Macro Strategies
This article analyzes financial trends for Chemours Company (NYSE: CC) and presents AI-generated trading strategies. It highlights conflicting sentiment across different time horizons, an exceptional risk-reward setup, and offers distinct position, momentum breakout, and risk hedging strategies for investors.
Y Intercept Hong Kong Ltd Takes Position in The Chemours Company $CC
Y Intercept Hong Kong Ltd disclosed a new position in The Chemours Company (NYSE:CC) during the third quarter, acquiring 134,096 shares valued at approximately $2.12 million. This investment comes as Chemours reported missed earnings estimates for Q3, with institutional ownership high at 76.26%. Analysts hold mixed views on the stock, with a consensus "Hold" rating and an average price target of $16.67.
Spotlight on Leadership: A Conversation With Denise Dignam, President and CEO of Chemours
Denise Dignam, President and CEO of Chemours, shares her leadership philosophy, challenges, and personal aspirations in a Q&A. She discusses the company's "Pathway to Thrive" strategy, emphasizing accountability, respect, and employee engagement. Dignam also highlights her commitment to continuous learning and the importance of supporting communities through tutoring.
